A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

This study is currently recruiting participants.
Verified June 2012 by Quest PharmaTech Inc.
Sponsor:
Information provided by (Responsible Party):
Quest PharmaTech Inc.
ClinicalTrials.gov Identifier:
NCT01616303
First received: May 30, 2012
Last updated: June 7, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)